Management of Non-Bleeding Gastric Varices

Primary Prophylaxis

The American Association for the Study of Liver Diseases recommends nonselective beta-blockers (propranolol or nadolol) as the preferred first-line therapy for prevention of first variceal hemorrhage, titrated to the maximal tolerated dose 1, 4
Beta-blockers reduce portal pressure by decreasing cardiac output and producing splanchnic vasoconstriction, with propranolol started at 40 mg daily 4
For patients with contraindications or intolerance to beta-blockers, endoscopic variceal ligation (EVL) should be considered, particularly for gastroesophageal varices type 1 (GOV1) 1, 2, 3
Endoscopic cyanoacrylate injection (ECI) may be more effective than EVL for fundal varices (GOV2 and IGV1), though data specifically for primary prophylaxis is limited 6

Regular monitoring of heart rate, blood pressure, and renal function is essential for patients on beta-blockers 4
Repeat endoscopy is recommended every 2-4 weeks until obliteration is complete for gastric varices treated endoscopically, and then yearly after endoscopic eradication 6

Nitrates alone should not be used for primary prophylaxis of variceal hemorrhage due to potential increased mortality, especially in patients older than 50 years 1, 2, 3
Shunt therapy (TIPS or surgical shunts) and endoscopic sclerotherapy should not be used for primary prophylaxis due to increased risk of encephalopathy, mortality, and higher mortality compared to sham therapy in randomized trials 1, 2, 3